Ranadhir Dey obtained his Ph.D. degree in microbiology from the Bose Institute, Kolkata, West Bengal, India, in 2006; then, he joined the Center for Biologics Evaluation and Research (CBER), FDA, Silver Spring, MD, USA, as an ORISE Postdoc Fellow. From his Ph.D. study, he developed his expertise in host parasite interaction and immunology in leishmaniasis. In his postdoctoral study, Dey focused on the characterization of the new gene in Leishmania and characterized a novel gene called Ldp27, which is involved in Leishmania growth in host cells. Dey became a Visiting Associate at the same division in CBER/FDA. He made the p27 gene delete cell line as a potential live attenuated vaccine candidate against leishmaniasis. His current research interest has been focused on testing the gene deleted parasite cell line as a live attenuated protective vaccine against leishmaniasis.
Biography Updated on 3 December 2013